Noticias

Curso: Riesgo Cardiovascular en el paciente con EPOC

Riesgo CV en el Paciente con EPOC: una visión multidisciplinar

diciembre 10, 2024

Participa en «Riesgo Cardiovascular en el Paciente con EPOC» de la Universidad de Barcelona. Modalidad presencial y online. ¡Inscríbete ahora!

Espacio para la Iniciativa ‘Sense Límits’ de SOCAP y Chiesi

Iniciativa ‘Sense Límits’ de SOCAP y Chiesi: Concienciación y Apoyo a Enfermedades Respiratorias como EPOC y Asma

diciembre 9, 2024

La Societat Catalana de Pneumologia (SOCAP) y Chiesi han lanzado la iniciativa ‘Sense Límits’ para concienciar sobre las enfermedades respiratorias, con actividades divulgativas y solidarias como espirometrías, pedaleos solidarios y marchas nórdicas, promoviendo la investigación científica y el cuidado de la salud respiratoria.

Respiratory microbiome and systemic inflammation in COPD

Relationship between Respiratory Microbiome and Systemic Inflammatory Markers in COPD: A Pilot Study

octubre 3, 2024

This study explores how changes in the respiratory microbiome relate to systemic inflammation in COPD patients. It highlights correlations between bacterial abundance, eosinophilic markers, and airflow limitation severity.

Change is in the air: key questions on the ‘Treatable Traits’ model for chronic airway diseases in primary care

septiembre 15, 2024

Explore Treatable Traits model for chronic airway diseases like asthma and COPD in primary care. Learn about seven key traits — airflow obstruction, eosinophilic inflammation, adherence, inhaler technique, smoking, low BMI/obesity and anxiety and depression — that guide personalized care.

Telomere length in patients with bronchiectasis

septiembre 6, 2024

This study investigates telomere length (TL) in bronchiectasis patients, comparing them to COPD patients and healthy controls. Findings show no significant TL reduction in bronchiectasis compared to controls, but a trend towards shorter TL in idiopathic cases. Further research is needed to understand TL’s role in bronchiectasis.

Pathophysiology and genomics of bronchiectasis

agosto 10, 2024

Explore the complex pathophysiology of bronchiectasis, including airway infection, chronic inflammation, and mucociliary dysfunction. Learn how genomic approaches, proteomics, and epigenomics offer new insights into disease endotypes and patient stratification for improved therapies. Discover the role of trained innate immunity in complementing current models.

Aging and Metabolic Changes in COPD Patients

agosto 4, 2024

Explore the metabolic changes in COPD patients, highlighting the influence of aging and sex, with pronounced effects in males. Discover how COPD affects protein metabolism and energy production, emphasizing early aging’s impact.

Systemic Inflammation Differences in Brain-vs. Circulatory-Dead Donors: Impact on Lung Transplant Recipients

junio 22, 2024

Explore how systemic inflammation differs between brain-dead (DBD) and circulatory-dead (DCD) lung donors and its impact on primary graft dysfunction (PGD) and mortality in lung transplant recipients.

Aspergillus Testing and Disease Outcomes in Bronchiectasis: Data From the EMBARC Registry

junio 3, 2024

Aspergillus-associated disorders in bronchiectasis, based on data from the EMBARC Registry. ABPA, AS, and AB: Impact on disease severity, diagnostic criteria efficacy, etc.

Changes in Blood Immune Cell Transcriptomes Associate With Disease Severity, Infection, and Inflammation in Bronchiectasis Patients

mayo 31, 2024

Marked differences in peripheral blood immune cell gene expression were observed between bronchiectasis patients and healthy controls.

Transcriptomic changes were associated with disease severity and airway inflammation identifying potential novel biomarkers and therapeutic targets.

Noticias

Riesgo CV en el Paciente con EPOC: una visión multidisciplinar

Iniciativa ‘Sense Límits’ de SOCAP y Chiesi: Concienciación y Apoyo a Enfermedades Respiratorias como EPOC y Asma

Change is in the air: key questions on the ‘Treatable Traits’ model for chronic airway diseases in primary care

Telomere length in patients with bronchiectasis

Pathophysiology and genomics of bronchiectasis

Aging and Metabolic Changes in COPD Patients

Systemic Inflammation Differences in Brain-vs. Circulatory-Dead Donors: Impact on Lung Transplant Recipients

Aspergillus Testing and Disease Outcomes in Bronchiectasis: Data From the EMBARC Registry

Changes in Blood Immune Cell Transcriptomes Associate With Disease Severity, Infection, and Inflammation in Bronchiectasis Patients

Cátedra UB de Salud Respiratoria

Recibe avisos de nuevas publicaciones

Legal

2024 © Cátedra UB de Salud Respiratoria. All rights reserved.

Entérate de
Nuestras Publicaciones

Noticias

Cátedra UB de Salud Respiratoria

Recibe avisos de nuevas publicaciones

Legal

2024 © Cátedra UB de Salud Respiratoria. All rights reserved.

Entérate de Nuestras Publicaciones

Entérate de
Nuestras Publicaciones